Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here’s how far they’ve come.

Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.

Numerous experimental vaccines that aim to provide multi-season protection are in human studies.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

Inflammation may be a strong contender for the connection between mom’s weight and children’s neurodevelopment, according to lab studies on animals.

Controversy surrounding a mathematical model to explain the so-called “greater variability of males” hypothesis fells two versions of a paper—but critics of the work wish it were still published.

Joey Ramp went back to college to study post-traumatic stress disorder. But the dogs that help her manage her own PTSD complicate her research career.

Researchers have flagged several issues with so-called SmartFlares over the years, and it’s still unclear why they don’t appear to work under certain circumstances.

Without knowing the cells’ mechanism of action, researchers question the best way to administer them to patients.